Condition: Rare Diseases · Sponsor: University Hospital Tuebingen
The aim of the STEP registry is to collect and evaluate experience and data on the diagnosis and treatment of rare childhood tumors in order to use the knowledge gained to improve the treatment prospects for our patients. The rarity of a disease should not be a disadvantage for the young patients.
This description comes directly from the study's public registry record.
Ines Brecht, PD Dr. med. · +49 7071 29 · ines.brecht@med.uni-tuebingen.de
Michael Abele, Dr. med. · +49 7071 29 · michael.abele@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| University Hospital Tübingen | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05773651